ArticleCommunity mental health journal2025
Psychometric Performance of the Cannabis Use Disorders Identification Test- Revised (CUDIT-R) in an Youth Clinical Sample.
Article in Community mental health journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Cannabis Use Disorders Identification Test-Revised (CUDIT-R) is an eight-item screening tool designed to identify problematic cannabis use. The present study intended to assess the psychometric properties of the measure in a youth sample. N = 76 participants completed the CUDIT-R and a measure of cannabis consumption. All participants underwent an assessment for a current cannabis use disorder using the Structured Clinical Interview for DSM-IV. The CUDIT-R exhibited good internal consistency (Cronbach's α = 0.76) and concurrent validity with a cannabis consumption measure. Discriminant validity was demonstrated with an area under the ROC curve of 0.96. The CUDIT-R proved to be a reliable and valid screening tool amongst youth with heavy cannabis use, which suggests the scale has clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.